TRU-SENTIMENT · DeltaNeutral
NVAX Trading Analysis - 10/05/2026 04:43 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
NVAX (Novavax Inc) at $12.52. True Sentiment Bullish, delta 40-60 call 98% / put 2%, call $9,290,184 vs put $138,848. RSI 85.2.
- Symbol
- NVAX
- Price
- $12.52
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- low
- Published
- 2026-10-05 16:43:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)Per True Sentiment options data for 2026-10-05:
Call Dollar Volume: $9,290,184.00 (98.5%) Put Dollar Volume: $138,848.00 (1.5%) Total: $9,429,032.00
Call contracts: 59,269 | Put contracts: 736 | Call trades: 30 | Put trades: 10. Sentiment flag: Bullish. The delta 40-60 filter captured 40 of 530 total options (7.5% filter ratio), reflecting pure directional conviction heavily skewed to calls.
This shows extreme near-term bullish positioning. However, the option spread engine returned no recommendation citing "Divergence detected between technical indicators and options sentiment" — technically overbought (RSI 85.22) vs sentimental blowout. That divergence is the key caution.
Key Statistics: NVAX
Fundamental Snapshot
Valuation
| P/E (trailing) | 3.40 |
| EPS (trailing 12 mo) | $-1.52 |
| Market cap | $2.07B |
| Shares outstanding | 164.9M |
Dividend
| Dividend yield | 0.00% |
Risk & range
| Beta | 2.71 |
| 52-week low | $6.20 |
| 52-week high | $11.97 |
| Historical volatility | 50.5% |
Ownership & trading
| Institutional ownership | 35.5% |
| Average daily volume | 5.2M sh |
Reported figures; no analyst estimates.
📈 Analysis
News Headlines & Context
Novavax (NVAX) has historically been a high-beta vaccine developer whose share price reacts sharply to regulatory and demand headlines. Recent general-knowledge context includes:
- FDA/CDC seasonal vaccine policy updates have acted as catalysts for NVAX in prior years, with renewed focus on alternative COVID-19 vaccine suppliers.
- Global advanced-purchase agreement renewals or manufacturing partnership announcements have previously driven sharp volume spikes.
- Biotech sector rotation and small-cap volatility have amplified NVAX moves relative to broader indices given its Beta of 2.71.
- No verified live X posts were retrieved for this run; sentiment context below is derived strictly from embedded options and price data.
Contextually, the embedded data shows a massive single-day volume surge on 2026-10-05 (24.4M shares vs 20-day avg of 4.78M) and an 98.5% bullish delta-weighted options flow, suggesting a catalyst-type move that aligns with the type of headline risk NVAX typically exhibits.
Fundamental Analysis
Based strictly on the provided FUNDAMENTALS data for NVAX as of 2026-10-05:
| Metric | Value |
|---|---|
| Trailing P/E | 3.40 |
| Trailing EPS | -1.52 |
| Market Cap | $2,071,721,760.00 |
| Shares Outstanding | 164,946,000 |
| Dividend Yield | 0.00% |
| Beta | 2.71 |
| 52-Week High | $11.97 |
| 52-Week Low | $6.20 |
| Institutional Ownership | 35.51% |
| Average Volume | 5,170,000 |
| Historical Volatility | 50.48% |
Revenue growth (YoY), gross/operating/net margins, ROE, Debt/Equity, and Free Cash Flow are not available in the embedded fundamentals (all null). The company is currently unprofitable with negative trailing EPS of -$1.52. The trailing P/E of 3.40 is mathematically distorted by negative earnings and should not be read as traditional cheapness; PEG, forward P/E, and price/book are null. Analyst consensus and target price are also null.
Fundamentally, the picture is weak (negative earnings, high beta, low institutional sponsorship at 35.51%), which diverges from the extreme short-term bullish options sentiment and the 2026-10-05 price breakout above the prior 52-week high of $11.97 (currently $12.99).
Current Market Position
Current price per indicators: $12.99 (2026-10-05 close). Daily history shows the stock opened 2026-10-05 at $10.47, traded as high as $13.38 and as low as $10.28, and closed at $12.99 on volume of 24,421,250 shares — roughly 5.1x the 20-day average volume of 4,780,885.
Minute bars for the final session (2026-10-05) show early strength to $13.38 at 15:35, then a fade to $12.52 by 15:55 on very heavy closing volume (1,482,450 shares in the last bar). The first bars of the window (2026-10-02 09:30) show a $10.80 open softening to $10.64 intrabar low, confirming the rally was concentrated in the 2026-10-05 session.
Key observational levels from data: prior 52-week high $11.97 (now support context), 2026-10-05 high $13.38 (near-term resistance), 30-day low $8.26, 30-day high $13.38.
Technical Analysis
Technical Indicators
SMAs are aligned bullishly: SMA 5 ($11.13) > SMA 20 ($10.32) > SMA 50 ($9.21), with price ($12.99) above all three. RSI 14 at 85.22 is deeply overbought (above 70 threshold), signaling exhausted short-term momentum. MACD (0.58) is above signal (0.47) with positive histogram (0.12), confirming bullish momentum but no bearish divergence in the embedded snap.
Bollinger Bands show price at $12.99 well above the upper band ($11.96), indicating an expansion breakout. The 30-day range is $8.26–$13.38; price is at the extreme top (97.2% of range). ATR 14 of $0.76 implies daily movement risk of roughly 5.8% of price.
True Sentiment Analysis (Delta 40-60 Options)
Per True Sentiment options data for 2026-10-05:
Call Dollar Volume: $9,290,184.00 (98.5%) Put Dollar Volume: $138,848.00 (1.5%) Total: $9,429,032.00
Call contracts: 59,269 | Put contracts: 736 | Call trades: 30 | Put trades: 10. Sentiment flag: Bullish. The delta 40-60 filter captured 40 of 530 total options (7.5% filter ratio), reflecting pure directional conviction heavily skewed to calls.
This shows extreme near-term bullish positioning. However, the option spread engine returned no recommendation citing "Divergence detected between technical indicators and options sentiment" — technically overbought (RSI 85.22) vs sentimental blowout. That divergence is the key caution.
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.